This funding opportunity supports research to develop and validate novel therapeutic interventions and testing strategies for neurological disorders, including epilepsy. It encourages human-focused testing approaches and preclinical model development to improve treatment, modification, and prevention of these conditions. Clinical trials are not allowed under this NOFO.
Eligible applicants include a wide range of government entities, educational institutions, nonprofits, for-profit organizations, tribal governments, and other specified organizations including foreign institutions. Specific eligibility details are provided in the full announcement.
